Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MMP17 |
| Upstream (Parents) |
|---|
| (<<) CYP2U1 → MMP17 |
| (<<) FZD5 → MMP17 |
| (<<) GNAL → MMP17 |
| (<<) HK1 → MMP17 |
| (<<) IL1A → MMP17 |
| (<<) OSBPL8 → MMP17 |
| (<<) PTPRE → MMP17 |
| (<<) PYGB → MMP17 |
| (<<) SMARCC2 → MMP17 |
| (<<) SPR → MMP17 |
| (<<) SYNJ2 → MMP17 |
| (<<) TARS → MMP17 |
| (<<) UBE2D4 → MMP17 |
| (<<) YWHAE → MMP17 |
| Downstream (Children) |
|---|
| MMP17 → KRTAP1-3 (>>) |
| MMP17 → MMP3 (>>) |
| MMP17 → RPS28 (>>) |
| MMP17 → UBE2J1 (>>) |
